MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gossamer Bio (GOSS) Ownership - Who owns Gossamer Bio?

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
Pharmaceuticals Major
Address
3115 Merryfield Row
Phone
+1 858 684-1300
Employees
162
Web
https://www.gossamerbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
80.27M
P/E Ratio
N/A
Total Cash
99.22M
Projected Growth
N/A
Total Debt
202.93M
Revenue
55.54M
Risk (Beta)
3.03
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
0.24 USD as % of share price
View a ticker or compare two or three
GOSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
3115 Merryfield Row
Phone
+1 858 684-1300
Employees
162
Web
https://www.gossamerbio.com